Blog - Page 6

If you think there’s too much red tape in your industry, spare a thought for pharma. Pharma manufacturers are subject to 76,000 restrictions–and with patients’ lives on the line, they need to take every one of them seriously. ...

Parsity Group successfully appoints Brendan O’Grady as CEO Formulations Business for Glenmark Pharmaceuticals. Parsity Group are pleased to announce their successful partnership with Glenmark Pharmaceuticals to secure Brendan O ...

6 Things That Could Challenge the Generics and Biosimilars Market Back in 2020, the worldwide pharmaceutical market had a value of $1.27 trillion; $387.92 billion and $28.235 billion of this was made up of the generics market and ...